One plan.
Every company.
Unlimited research, valuation models, and catalyst tracking on any biotech on the market. The equivalent sell-side terminal runs about $25,000 a year.
Cancel anytime
- Unlimited company research
- AI valuation: rNPV, DCF, comps
- Full drug pipeline analysis
- Catalyst calendar & event tracking
- Bull / bear cases per ticker
- Unlimited watchlists
7 days free · No card required
Creating your account starts a 7-day free trial — no card needed. You're only charged once you choose to subscribe.
Not ready — let me try a ticker firstFuzeBio MCP Server
The same research, called directly from Claude or any other MCP client. Ask in your own words; the models, filings, and trial data come back in the chat.
- Company research & valuation dashboards
- Drug asset and disease landscape lookups
- Catalyst pulse and company screening
- Your watchlists, read from your client
- Adjustable rNPV assumptions from chat
- Works with Claude, Cursor, and any MCP client
Billed separately from Pro · No free trial · Cancel anytime
How we compare
| Feature | FuzeBio$29/mo | Seeking Alpha$299/yr | Bloomberg$25k/yr | ChatGPT$20/mo |
|---|---|---|---|---|
Adjustable rNPV/DCF Models Drug-by-drug models with adjustable PoS, peak sales, discount rates | ||||
Plain English + Full Methodology Complex trial data explained clearly, with links to sources | ||||
Real-Time SEC, FDA, Clinical Data Live feeds from EDGAR, ClinicalTrials.gov, FDA databases | ||||
Hours of Research in Seconds Bull/bear cases, catalyst calendars, pipeline views—instantly | ||||
Biotech-Specific UI Built specifically for biotech research workflow |
Common questions
How does the free trial work?
Seven days of full access, including valuation models. No card required to start, so there is nothing to cancel if you decide against it — the trial simply ends.
Can I cancel anytime?
Yes, one click from your profile. Access continues to the end of the period you have already paid for, and nothing renews after that.
What is in Pro versus the trial?
Nothing is held back during the trial — you see the product as a subscriber sees it, valuation models included. After seven days, continuing requires Pro.
Is the MCP server included in Pro?
No — they are two separate subscriptions, and each is bought on its own. Pro is the web app at $29/month; the MCP server is $14/month and puts the same research inside Claude or another MCP client. You can hold either, both, or neither, and cancelling one leaves the other running.
What data sources do you use?
SEC EDGAR, ClinicalTrials.gov, FDA databases, PubMed, company press releases, and market data feeds. All public, all read at the moment you request a report rather than pulled from a stale cache.
How do I know the AI is not making things up?
Every claim links back to the document it came from, so you can check any number in one click. Where a company has not disclosed something, the report says the data is unavailable instead of guessing.
Is this financial advice?
No. FuzeBio is a research tool and we are not registered investment advisers. Every decision, and its outcome, is yours.